Migraine

CBT for Insomnia May Reduce Headache Frequency in Chronic Migraine

CBT for Insomnia May Reduce Headache Frequency in Chronic Migraine

By

In patients with comorbid insomnia and chronic migraine, a cognitive behavioral treatment of insomnia may effectively reduce headache frequency.

Remission Rates and Predictors of Chronic Headache

Remission Rates and Predictors of Chronic Headache

By

Investigators examined remission rates and predictors of remission in patients with chronic headache over 11 years.

Neck Pain a Migraine Symptom, Rather Than a Migraine Trigger

Neck Pain a Migraine Symptom, Rather Than a Migraine Trigger

By

Neck pain is a symptom of migraine only, not the result of an underlying muscle dysfunction that triggers migraine attacks.

Qualitative Analysis of Visual Symptoms in Childhood Migraine

Qualitative Analysis of Visual Symptoms in Childhood Migraine

By

Investigators examined the characteristics of visual symptoms during migraine attacks in children and adolescents.

Intravenous Aminophylline Safe and Effective for Postdural Puncture Headache

Intravenous Aminophylline Safe and Effective for Postdural Puncture Headache

By

Investigators examine the safety and efficacy of intravenous aminophylline for postdural puncture headaches.

FDA Approves Aimovig for Migraine Prevention

FDA Approves Aimovig for Migraine Prevention

By

The first-in-class migraine prevention drug will be available to patients within 1 week of the approval.

Increased Risk for Developing Hypertension in Women With Migraine

Increased Risk for Developing Hypertension in Women With Migraine

By

Investigators conducted a prospective cohort study to examine the risk of incident hypertension in women with migraine.

Managing Pediatric Migraine: Current Therapies and Future Directions

Managing Pediatric Migraine: Current Therapies and Future Directions

By

Migraine is highly prevalent in children and adolescents, affecting almost 10% of children between 5 and 15 years old and 30% of adolescents between 15 and 19 years old.

NPRS, Neck Disability Index: Reliable Assessment Tools in the Short-Term

NPRS, Neck Disability Index: Reliable Assessment Tools in the Short-Term

By

The Neck Disability Index, and to a lesser extent, the Numeric Pain Rating Scale, may represent reliable measures for patients to self-report cervicogenic headache-associated disability and pain in the short-term.

Migraine Linked With Increased Long-Term Cardiovascular, Cerebrovascular Event Risk

Migraine Linked With Increased Long-Term Cardiovascular, Cerebrovascular Event Risk

By

Migraine headache is associated with a higher risk for major adverse cardiovascular and cerebrovascular events.

Galcanezumab Effective in Phase 3 Episodic Cluster Headache Study

Galcanezumab Effective in Phase 3 Episodic Cluster Headache Study

By

The episodic cluster headache trial included a total of 106 patients with an average of 17.5 cluster headache attacks per week at baseline.

Enhanced Activation of the Spinal Trigeminal Nucleus in Chronic Migraine During Visual Stimulation

Enhanced Activation of the Spinal Trigeminal Nucleus in Chronic Migraine During Visual Stimulation

By

Patients with chronic migraine exposed to visual stimulation may have enhanced activity in the spinal trigeminal nucleus and the right superior colliculus compared with healthy individuals.

Migraine a Common Comorbidity in Individuals With Sarcoidosis

Migraine a Common Comorbidity in Individuals With Sarcoidosis

By

The frequency of migraine and sarcoidosis comorbidity was examined in a cohort study.

Antidepressant Medications and Headache: Is There a Link?

Antidepressant Medications and Headache: Is There a Link?

By

Compared to placebo, selective serotonin reuptake inhibitors (SSRIs) were associated with a significantly higher risk of headache (risk ratio [RR] 1.06, 95% CI: 1.00 to 1.13; P =.045).

Beneficial Effect of Aerobic Exercise in Migraine via Modulation of Avoidance Behavior

Beneficial Effect of Aerobic Exercise in Migraine via Modulation of Avoidance Behavior

By

The effect of aerobic exercise in reducing migraine-associated burden in individuals with comorbid tension-type headache and neck pain may not be mediated by an effect on nociceptive pathways.

Aerobic Exercise Significantly Improves Symptom Burden for Migraineurs

Aerobic Exercise Significantly Improves Symptom Burden for Migraineurs

By

Aerobic exercise may improve migraine frequency, intensity of pain, and the duration of tension-type headache.

Avoiding Treatment Effect Overestimation in Medication-Overuse Headache

Avoiding Treatment Effect Overestimation in Medication-Overuse Headache

By

A period of observation after an educational session may be important to confirm medication-overuse headache (MOH) diagnoses.

Hormonal Factors May Affect Intensity of Migraine During Pregnancy

Hormonal Factors May Affect Intensity of Migraine During Pregnancy

By

Researchers aim to determine a pattern of migraine, in terms of frequency, intensity, and analgesic use, in women with and without menstrual migraine.

Eptinezumab for Frequent Episodic Migraine: Results of Phase 3 PROMISE-1 Study

Eptinezumab for Frequent Episodic Migraine: Results of Phase 3 PROMISE-1 Study

By

Eptinezumab, a humanized monoclonal antibody specific to calcitonin gene-related peptide, may be an effective prophylactic for individuals with frequent episodic migraines.

New Zolmitriptan Intracutaneous System Safe and Effective for Migraine

New Zolmitriptan Intracutaneous System Safe and Effective for Migraine

By

Researchers conducted a randomized, double-blond, placebo-controlled, dose-ranging trial to assess the use of a new zolmitriptan intracutaneous delivery system in adults with migraine headache.

Pain, Psychiatric Comorbidities More Common in Chronic vs Episodic Migraine

Pain, Psychiatric Comorbidities More Common in Chronic vs Episodic Migraine

By

Individuals with chronic vs episodic migraine may be more likely to experience chronic back pain, chronic pain, neck pain, anxiety, and depression.

Erenumab Shown to Reduce Headache Days for Patients with Episodic Migraine

Erenumab Shown to Reduce Headache Days for Patients with Episodic Migraine

By

Researchers assessed the ability of erenumab to decrease the mean number of acute headache days in patients with episodic migraine.

Peripheral Nerve Blocks for Headache Disorders: Expert Roundtable

Peripheral Nerve Blocks for Headache Disorders: Expert Roundtable

By

Although high-quality studies on the use of peripheral nerve blocks for the treatment of headache disorders are scarce, results observed in clinical practice support their use.

OnabotulinumtoxinA May Reduce Headache Days in Chronic Migraine

OnabotulinumtoxinA May Reduce Headache Days in Chronic Migraine

By

Treating chronic migraine with onabotulinumtoxinA may reduce the number of headache days when administered according to the National Institute for Health and Care Excellence guidelines.

Balloon Angioplasty Provides Clinical Relief in Headache-Positive MS

Balloon Angioplasty Provides Clinical Relief in Headache-Positive MS

By

Percutaneous transluminal angioplasty maybe beneficial for reducing headaches in relapsing remitting and secondary progressive multiple sclerosis.

Positive Results for Ubrogepant in Phase 3 Migraine Trial

Positive Results for Ubrogepant in Phase 3 Migraine Trial

By

A total of 1,327 migraine patients were treated in the study for a single migraine attack. At 2 hours after migraine attack, 19.2% (n=423) and 21.2% (n=448) of ubrogepant 50mg and 100mg were pain free, respectively.

Headache in Older Adults: Unique Causes and Treatments

Headache in Older Adults: Unique Causes and Treatments

By

It is important for clinicians to quickly and accurately determine potential underlying causes and to prescribe treatments that take into account comorbidities and medications that older patients may be taking for them.

White Matter Hyperintensities Linked to Tension-Type Headaches

White Matter Hyperintensities Linked to Tension-Type Headaches

By

Investigators sought to determine the relationship between headache and white matter hyperintensities.

Transcranial Magnetic Stimulation May Prevent Migraine in Adolescents

Transcranial Magnetic Stimulation May Prevent Migraine in Adolescents

By

Researchers conducted an open-label prospective study to assess the use of single-pulse transcranial magnetic stimulation for the management of migraine headache in adolescents.

Tobacco Exposure Influences Cluster Headache Presentation

Tobacco Exposure Influences Cluster Headache Presentation

The United States Cluster Headache Survey assessed tobacco exposure in individuals with cluster headaches.

Sign Up for Free e-Newsletters